Anaphylaxis to lansoprazole with tolerance to other proton pump inhibitors

In Young Park; Byung Joo Do; Jae Sung Ahn; Jae Hyuk Lee; Gye Yeon Lee; Sunhyung Kim; Jeong-Hee Choi

doi:10.4168/aard.2014.2.5.383

Journal List > Allergy Asthma Respir Dis > v.2(5) > 1059062

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Park, Do, Ahn, Lee, Lee, Kim, and Choi: Anaphylaxis to lansoprazole with tolerance to other proton pump inhibitors

Case Report

Allergy, Asthma & Respiratory Disease 2014; 2(5): 383-386.

Published online: 28 November 2014

DOI: https://doi.org/10.4168/aard.2014.2.5.383

Anaphylaxis to lansoprazole with tolerance to other proton pump inhibitors

In Young Park, Byung Joo Do, Jae Sung Ahn, Jae Hyuk Lee, Gye Yeon Lee, Sunhyung Kim, Jeong-Hee Choi

Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.

Correspondence to: Jeong-Hee Choi. Department of Pulmonology & Allergy, Hallym University Dongtan Sacred Heart Hospital, 7 Keunjaebong-gil, Hwaseong 445-170, Korea. Tel: +82-31-8086-2928, Fax: +82-31-8086-2482, mdqueen@hallym.or.kr

Received 2 May 2014 Revised 2 July 2014 Accepted 21 July 2014

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).

Abstract

Anaphylaxis to proton pump inhibitors (PPIs) has rarely been reported. Different patterns of cross-reactivity between PPIs have also been demonstrated using skin tests. Here, we report a case of anaphylaxis to lansoprazole with tolerance to other commercially available PPIs, which was proved by skin tests and oral provocation tests (OPTs). A 47-year-old female patient visited our Emergency Department with a sudden onset of whole body urticaria, facial swelling, dyspnea, and loss of consciousness that developed 1 hour after ingestion of 30 mg of lansoprazole for her episodic epigastric soreness. The skin prick test (SPT) and the intradermal test (IDT) with lansoprazole, esomeprazole, rabeprazole, and pantoprazole were performed. Lansoprazole showed positive reactions in both the SPT (3 mg/mL) and the IDT (0.003 mg/mL). Rabeprazole (3 mg/mL) showed a positive reaction only in IDT. The SPT and the IDT with esomeprazole and pantoprazole were all negative. The OPT with 30 mg of lansoprazole was positive (showing generalized rash and facial swelling 30 minuites after ingestion), while OPTs with esomeprazole, pantoprazole, and rabeprazole were all negative. Other PPIs could be safe alternatives in cases of anaphylaxis to 1 PPI. Skin tests seem to be helpful to define cross-reactivity between PPIs.

Keywords: Proton pump inhibitors, Anaphylaxis, Cross-reactions, Skin tests

Figures and Tables

Fig. 1

Chemical structure of various proton pump inhibitors.

Table 1

Results of the intradermal tests with proton pump inhibitors in the patient

ND, not done.

^*The concentration of histamine is 0.1 mg/mL. ^†The concentration of the drugs (1:1) is 3 mg/mL.

References

1. Gremse DA. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses. Expert Opin Pharmacother. 2001; 2:1663–1670.

2. Chang YS. Hypersensitivity reactions to proton pump inhibitors. Curr Opin Allergy Clin Immunol. 2012; 12:348–353.

3. Bose S, Guyer A, Long A, Banerji A. Evaluation and management of hypersensitivity to proton pump inhibitors. Ann Allergy Asthma Immunol. 2013; 111:452–457.

4. Choi SW, Han JM, Bae YJ, Lee YS, Cho YS, Moon HB, et al. Lessons from two cases of anaphylaxis to proton pump inhibitors. J Clin Pharm Ther. 2012; 37:614–616.

5. Sobrevia Elfau MT, Garces Sotillos M, Ferrer Claveria L, Segura Arazuri N, Monzon Ballarin S, Colas Sanz C. Study of cross-reactivity between proton pump inhibitors. J Investig Allergol Clin Immunol. 2010; 20:157–161.

6. Lobera T, Navarro B, Del Pozo MD, Gonzalez I, Blasco A, Escudero R, et al. Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors. J Investig Allergol Clin Immunol. 2009; 19:57–60.

7. Bonadonna P, Lombardo C, Bortolami O, Bircher A, Scherer K, Barbaud A, et al. Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test. J Allergy Clin Immunol. 2012; 130:547–549.

8. Kepil Ozdemir S, Yılmaz I, Aydin O, Buyukozturk S, Gelincik A, Demirturk M, et al. Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity. Allergy. 2013; 68:1008–1014.

9. Garrido Fernandez S, Cumplido JA, Rabano A, Martinez D, Blanco C, Carrillo T. Allergy to proton pump inhibitors: diagnosis and assessment of cross-reactivity. J Investig Allergol Clin Immunol. 2008; 18:140–141.

10. Natsch S, Vinks MH, Voogt AK, Mees EB, Meyboom RH. Anaphylactic reactions to proton-pump inhibitors. Ann Pharmacother. 2000; 34:474–476.

11. Vovolis V, Koutsostathis N, Stefanaki E. IgE-mediated anaphylaxis to proton pump inhibitors: cross-reacting study. Allergy. 2008; 63:1251–1252.

12. Perez Pimiento AJ, Prieto Lastra L, Rodriguez Cabreros MI, Gonzalez Sanchez LA, Mosquera MR, Cubero AG. Hypersensitivity to lansoprazole and rabeprazole with tolerance to other proton pump inhibitors. J Allergy Clin Immunol. 2006; 117:707–708.

13. Kollmeier AP, Eddleston J, Zuraw BL, Christiansen SC. Recurrent anaphylaxis linked to pantoprazole. J Allergy Clin Immunol. 2004; 114:975–977.

14. Demirkan K, Bozkurt B, Karakaya G, Kalyoncu AF. Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature. J Investig Allergol Clin Immunol. 2006; 16:203–209.

15. Porcel S, Rodriguez A, Jimenez S, Alvarado M, Hernandez J. Allergy to lansoprazole: study of cross-reactivity among proton-pump inhibitors. Allergy. 2005; 60:1087–1088.

TOOLS

Similar articles